Your browser doesn't support javascript.
loading
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Koiwa, Fumihiko; Yokoyama, Keitaro; Fukagawa, Masafumi; Terao, Akira; Akizawa, Tadao.
Affiliation
  • Koiwa F; Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Yokoyama K; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
  • Terao A; Biostatistics, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan.
  • Akizawa T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nephrology (Carlton) ; 22(4): 293-300, 2017 Apr.
Article in En | MEDLINE | ID: mdl-27496336
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphorus / Sucrose / Ferric Compounds / Chelating Agents / Renal Dialysis / Renal Insufficiency, Chronic / Hyperphosphatemia / Sevelamer Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Country/Region as subject: Asia Language: En Journal: Nephrology (Carlton) Year: 2017 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphorus / Sucrose / Ferric Compounds / Chelating Agents / Renal Dialysis / Renal Insufficiency, Chronic / Hyperphosphatemia / Sevelamer Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Country/Region as subject: Asia Language: En Journal: Nephrology (Carlton) Year: 2017 Type: Article Affiliation country: Japan